References
- Trager J, Ward MM. Mortality and causes of death in SLE. Curr Opin Rheumatol 2001; 13(5)345–351
- Hahn BH, McMahon M. Atherosclerosis and SLE: The role of altered lipids and of autoAB. Lupus 2008; 17(5)368–370
- McMahon M, Hahn BH. Atherosclerosis and SLE: Mechanistic basis of the association. Curr Opin Immunol 2007; 19(6)633–639
- Matsuura E, Hughes GR, Khamashta MA. Oxidation of LDL and its clinical implication. Autoimmun Rev 2008; 7(7)558–566
- Lara L, Rivera H, Pérez-P C, Blanca I, Bianco NE, De Sanctis JB. Low density lipoprotein receptor expression and function in human polymorphonuclear leukocytes. Clin Exp Immunol 1997; 107: 205–212
- De Sanctis JB, Blanca I, Radzioch D, Bianco N. Expression and function of low density lipoprotein receptors in CD3− CD16+CD56+ cells: Effect of interleukin 2. Cell Immunol 1996; 127: 18–29
- Stulnig TM, Klocker H, Harwood HJ, Jr, Jürgens G, Schönitzer D, Jarosch E, Huber LA, Amberger A, Wick G. In vivo LDL receptor and HMG-CoA reductase regulation in human lymphocytes and its alterations during aging. Arterioscler Thromb Vasc Biol 1995; 15(7)872–878
- Raghow R, Yellaturu C, Deng X, Park EA, Elam MB. SREBPs: The crossroads of physiological and pathological lipid homeostasis. Trends Endocrinol Metab 2008; 19(2)65–73
- Ferré P, Foufelle F. SREBP-1c transcription factor and lipid homeostasis: Clinical perspective. Horm Res 2007; 68(2)72–82
- Roder K, Schweizer M. Retinoic acid-mediated transcription and maturation of SREBP-1c regulates fatty acid synthase via cis-elements responsible for nutritional regulation. Biochem Soc Trans 2007; 35(Pt 5)1211–1214
- Bennett DJ, Cooke AJ, Edwards AS. Non-steroidal LXR agonists: An emerging therapeutic strategy for the treatment of atherosclerosis. Recent Pat Cardiovasc Drug Discov 2006; 1(1)21–46